Latest Breaking News On - Carlo incerti - Page 2 : comparemela.com

Inversago Pharma Inc : Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors

Board appointments following recent $95 million CAD Series C Financing Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse

Dennis kimInversago pharmaKostenloser wertpapierhandelTara nickersonCarlo incertiEd mathersEnterprise associates incPartner at new enterprise associatesInversago pharma incGeneral partnerNew enterprise associatesChief executive officerDiabetic kidney diseasesEnterprise associatesUnited nations principlesDiabetic kidney disease

Azafaros B V : Azafaros Appoints Stefano Portolano, M D , as Chief Executive Officer

Azafaros B V : Azafaros Appoints Stefano Portolano, M D , as Chief Executive Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNoord hollandOlivier morandKostenloser wertpapierhandelSophia hergenhanCarlo incertiSchroder adveqNapoli federicoUniversity of californiaAmsterdam university medical centerLeiden universityUltragenyx pharmaceuticalsTrophic communicationsStefano portolanoChief executive officer

VectorY Raises €31 Million in Seed Financing to Develop Next-Generation Gene Therapies Aimed at Muscular and CNS Disorders

VectorY Raises €31 Million in Seed Financing to Develop Next-Generation Gene Therapies Aimed at Muscular and CNS Disorders
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMarco boorsmaSanofi genzymeEli lillyCarlo incertiSander van deventerAlexander vosCompany board of directorsEuropean recovery programmeDutch venture initiativeBiogeneration venturesVectory therapeuticsAmsterdam science parkChief executive officerChief technology officerChief medical officer

VectorY Raises €31M in Seed Funding

VectorY Raises €31M in Seed Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMarco boorsmaSanofi genzymeEli lillyCarlo incertiSander van deventerAlexander vosVectory therapeuticsAmsterdam science parkChief medical officerGeneral partnerநூற்த் ஹாலண்ட்மார்கோ பூர்ஸ்மாஎலி லில்லிசாண்டர் வேன் டெவெண்டேர்அலெக்சாண்டர் வாஸ்

Numab Therapeutics schließt überzeichnete Serie-C-Finanzierung über 100 Millionen CHF ab

Numab Therapeutics schließt überzeichnete Serie-C-Finanzierung über 100 Millionen CHF ab
bionity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionity.com Daily Mail and Mail on Sunday newspapers.

Carlo incertiMatthias fehrDevelopment of nmKrebsindikationen as well the developmentInvestors novo holdingsNumab therapeuticsNew investors novo holdingsForbion growth opportunitiesCormorant assetRtw reliableHbm partnerChief executiveTherapeutic strategyHas becomeMatch tm technologiesPrivate equity